Uniphar, the Irish-listed healthcare group, has acquired BModesto Group, a Dutch pharmaceutical business, in a deal worth €75 million.
BModesto, which reported EBDITA of €7.7 million in 2021, focuses on the distribution of medicines, clinical trial services, market authorisation holder and medical device distribution.Uniphar on Monday said the company would be integrated into its Product Access division of ...
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: